Source: Annual Congress 2004 - COPD: insights from structure and function
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. P. Swanney, L. E. Beckert, C. M. Frampton, R. L. Jensen, R. O. Crapo (Christchurch, New Zealand; Salt Lake City, United States Of America). FEF_25-75% based on FEV₆ is significantly less variable than the traditional FEF_25-75%. Eur Respir J 2004; 24: Suppl. 48, 822

Member's Comments

No comment yet.

Related content which might interest you: Assessment of a 20% fall in FEF25-75% in patients with negative methacholine provocation test Source: Annual Congress 2008 - Asthma: growing understanding of influential factors Year: 2008 FEF25-75% should not yet be used to define a bronchodilator response in individuals Source: Annual Congress 2005 - Spirometry - now and in the future Year: 2005 Ratio between forced expiratory flow between 25% and 75% of VC and FVC as a determinant of airway reactivity and sensitivity to methacholine Source: Eur Respir J 2006; 28: Suppl. 50, 219s Year: 2006 Correlation between reduced  forced expiratory flow between 25% and 75% (FEF 25-75%) and a positive methacholine challenge test (MCT) in adults with non-obstructive baseline spirometry. Source: International Congress 2018 – Clinical markers of asthma Year: 2018 Correlation between total score of asthma control test and FEV1 and FEF50% in 12-18 years old children Source: Annual Congress 2007 - Assessing asthma severity and control in children Year: 2007 Spirometric reference equations for European females and males aged 65-85 yrs Source: Eur Respir J 2004; 24: 397-405 Year: 2004 Measurement of FEF25–75% and FEF75% does not contribute to clinical decision making Source: Eur Respir J 2014; 43: 1051-1058 Year: 2014 The FEF25-75/FVC ratio is related to exercise responsiveness in asthmatic children Source: Eur Respir J 2001; 18: Suppl. 33, 119s Year: 2001 Midflows do not vary independently of FEV1 and FVC Source: Annual Congress 2010 - Quality measurement and improvement in lung function Year: 2010 Assessment of the relationship between FEF25-75/FVC ratio and reversibility in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 810s Year: 2006 FEV6 and FEV1/FEV6 have higher association with small airway function and oxygen saturation than FVC and FEV1/FVC in patients with asthma. Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers Year: 2020 Bronchyal hyperreactivity estimated by bronchodilatator test and FEF25-75/FVC ratio Source: Eur Respir J 2007; 30: Suppl. 51, 744s Year: 2007 Is the forced expiratory volume in 6 seconds (FEV6) a more reproducible and accurate measurement than forced vital capacity (FVC) in obstructive and normal/restrictive patients Source: Eur Respir J 2001; 18: Suppl. 33, 13s Year: 2001 Should maximal mid-expiratory flow (MMEF) be considered more in COPD? Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 FEV6 and FEV1/FEV6 as an alternative for FVC and FEV1/FVC in monitoring response to prednisolone treatment Source: Annual Congress 2010 - Quality measurement and improvement in lung function Year: 2010 Annual decline in forced expiratory volume in 1 sec (FEV1) in patients with COPD before and after introduction of tiotropium Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008 Within session variability of FEV1 and FVC pre- and post-bronchodilation Source: International Congress 2019 – Quality, performance and interpretation of lung function testing Year: 2019 HMOX1 and GST variants modify attenuation of FEF25-75% decline due to PM10 reduction Source: Eur Respir J 2010; 35: 505-514 Year: 2010 Evaluation of IL-17 and FEF25-75 in patients with uncontrolled moderate asthma Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities Year: 2020 Reference values for FEV1, FVC and FEV1/FVC in Norway Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015